Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

Notable among these examples is that of a 16-year-old boy, who was found with a large number of vaporiser pods in his home.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

As of June 22, there were 1,648 cases of the new variant reported across 38 countries. In the UK, the latest data by the UK ...